新型光固化水凝胶根管充填材料的生物相容性:体内外分析
本研究在大鼠下颌第一磨牙上实施故意超预备与超充填,分4组比较OdneFill、牙胶加AH Plus、单纯预备与健康牙,并于3、28、90天行显微CT、组织学与免疫组化分析,同时用RAW 264.7细胞评估细胞毒性与炎性因子。结果显示各组骨吸收无显著差异,但AH Plus在90天炎症评分及中性粒细胞、巨噬细胞浸润高于单纯预备组,而OdneFill与单纯预备组相当且不影响细胞活力。结论为OdneFill生物相容性优于AH Plus、炎症反应轻微。
要点
- OdneFill在大鼠根尖周组织中炎症反应与单纯预备组相当,优于AH Plus。
- AH Plus在90天时炎症评分及中性粒细胞、巨噬细胞浸润显著高于单纯预备组。
- OdneFill不影响RAW 264.7细胞活力,AH Plus提取物降低细胞活力并上调IL-1β与IL-6。
核心结论
- OdneFill表现出优于AH Plus的生物相容性和轻微的炎症反应。
研究设计与样本
- 10周龄雄性大鼠下颌第一磨牙行故意超预备与超充填,分4组:单纯预备、OdneFill、牙胶+AH Plus、健康牙。
- 于3、28、90天取材行显微CT、组织学与免疫组化分析,采用双因素方差分析与Tukey事后检验。
- 用RAW 264.7细胞评估细胞毒性与促炎细胞因子表达,采用单因素方差分析与Tukey检验(α=0.05)。
主要发现
- 显微CT显示各组骨吸收无显著差异(P > .05)。
- 90天时AH Plus炎症评分较高(评分1占1%-90%,评分2占10%),免疫染色中性粒细胞与巨噬细胞浸润较单纯预备组增加(P < .05)。
- OdneFill结果与单纯预备组相当(评分0占0%-50%,评分1占30%,评分2占20%,P > .05)。
- OdneFill不影响RAW 264.7细胞活力,而AH Plus提取物降低细胞活力并上调白细胞介素-1β和白细胞介素-6等炎性因子。
关键数值与推荐
- 骨吸收组间比较P > .05。
- 90天AH Plus与单纯预备组炎症比较P < .05;OdneFill与单纯预备组比较P > .05。
- 细胞实验统计显著性水平α=0.05。
临床怎么用
- 提示OdneFill对根尖周组织炎症刺激较小,可作为根管充填材料的候选。
- 对炎症敏感或根尖周条件欠佳病例,材料选择时可参考其较低的细胞毒性与炎性因子表达。
- 仍需结合临床操作与长期随访综合判断材料适用性。
局限性
- 证据来自大鼠模型与RAW 264.7细胞,尚不能直接外推至人体临床。
- 样本为10周龄雄性大鼠,未涵盖不同年龄、性别及全身状态。
- 观察期最长为90天,缺乏更长周期与临床结局数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: This study aims to evaluate the biocompatibility of a new light-curable hydrogel-based root canal obturation material, OdneFill, through in vivo and in vitro analyses. METHODS: Intentional overinstrumentation and overobturation were performed on the mandibular first molars of 10-week-old male rats, divided into 4 groups: group 1 (instrumentation only), group 2 (OdneFill), group 3 (gutta-percha + AH Plus), and group 4 (sound teeth). Mandibles were dissected after 3, 28, and 90 days for micro-computed tomography, histological analysis, and immunohistochemical staining and analyzed by two-way analysis of variance and post hoc Tukey test. Cytotoxicity and proinflammatory cytokine expression were assessed using RAW 264.7 cells and analyzed by 1-way analysis of variance and Tukey test (α = 0.05). RESULTS: Micro-computed tomographic analysis showed no significant difference in bone resorption (P > .05). However, AH Plus exhibited a higher inflammatory score (score: 1%-90%, score: 2%-10%) with increased neutrophil and macrophage infiltration in immunostaining (P < .05) compared to the instrumentation only group at day 90. In contrast, Odnefill showed comparable results (score: 0%-50%, score: 1%-30%, score: 2%-20%) to the instrumentation-only group (P > .05). Moreover, Odnefill did not affect the viability of RAW 264.7 cells, whereas the AH Plus extract decreased cell viability and upregulated inflammatory cytokines such as interleukin-1 beta and interleukin-6. CONCLUSIONS: OdneFill demonstrated superior biocompatibility, and a minimal inflammatory response compared to AH Plus.
引用
- Kyaw MS, Yahata Y, Nakano M, et al. Biocompatibility of a Novel Light-Curable Hydrogel-Based Root Canal Obturation Material: In Vivo and In Vitro Analyses. J Endod. 2025. PMID: 40885490. doi:10.1016/j.joen.2025.08.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。